Zacks Research Has Optimistic Outlook of THC Q3 Earnings

Tenet Healthcare Corporation (NYSE:THC) – Stock analysts at Zacks Research upped their Q3 2026 earnings per share estimates for shares of Tenet Healthcare in a research report issued to clients and investors on Wednesday, February 25th. Zacks Research analyst Team now anticipates that the company will earn $4.08 per share for the quarter, up from their prior estimate of $3.78. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $4.44 EPS, Q1 2027 earnings at $4.31 EPS, Q2 2027 earnings at $4.75 EPS and FY2028 earnings at $17.80 EPS.

A number of other equities analysts have also recently commented on THC. Truist Financial lifted their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. KeyCorp lifted their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. UBS Group boosted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, Leerink Partners increased their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Trading Down 0.4%

Shares of NYSE THC opened at $238.68 on Friday. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $240.83. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The business’s 50 day moving average is $206.02 and its two-hundred day moving average is $199.74. The stock has a market capitalization of $20.76 billion, a P/E ratio of 15.41, a PEG ratio of 1.18 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same quarter in the prior year, the firm earned $3.44 earnings per share. Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently bought and sold shares of the stock. Triumph Capital Management acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare in the fourth quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the 4th quarter worth about $29,000. William B. Walkup & Associates Inc. purchased a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $32,000. Finally, Westside Investment Management Inc. raised its holdings in Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.